Accès membre
Logo Groupe FILO

National Cooperative Group
of research in the field of Chronic Lymphoid Leukemia (CLL) Acute Myeloblastic Leukemia (AML)

Cooperative Group presentation

FILO is a Cooperative Group aiming at implementing and carrying out biomedical, epidemiological, clinical, pharmacological and biological research in the field of Chronic Lymphoid Leukemia (CLL), Waldenström's Disease (MW), Acute Myeloblastic Leukemia (LAM) and other pathological conditions such as Myeloproliferative Syndromes. It also endeavors to pursue educational and / or informative actions intended for medical professionals and patients.

Read More ...
Pictogramme chercheur
Médecin et un patient - Groupe FILO

All news

More details


Recommandations FILO LLC: actualisation of treatment algorithms 1st line and relapse

One year after the publication of recommandations from the group for the diagnosis and treatment of CLL (Hemasphere 2020 Sep 23 ;4(5) : e473), here is the actualisation of treatment algorithms for first line and relapse according to regulation evolution since end of 2020.

Recommandations from the Concil of Vaccinal Strategy Orientation

The Concil of Vaccinal Strategy Orientation (Conseil d’Orientation de la Stratégie Vaccinale, COSV) issued on 19th of november 2021 new recommandations about protection of immunodepressed patients against Covid-19. These recommandations concern the vaccine, the antibody level considered as efficient for protection, and the use of monoclonal antibodies ...

All news
Microscope, Chercheurs, Leucémie